MergerLinks Header Logo

Request Deal Involvement

Ampersand-backed Alliance Pharma completed the acquisition of the drug development solutions business from LGC Group.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Wolf Theiss

legal advisors

Wolf Theiss

Gibson Dunn & Crutcher

legal advisors

Gibson Dunn & Crutcher

Lincoln International

financial advisors

Lincoln International

Ashurst

legal advisors

Ashurst

PricewaterhouseCoopers

tax advisors

PricewaterhouseCoopers

or

Principals

ALLIANCE PHARMA LC

bidder

ALLIANCE PHARMA LC

KKR & CO

bidder

KKR & CO

AMPERSAND CAPITAL PARTNERS

bidder

AMPERSAND CAPITAL PARTNERS

LGC GROUP LTD

vendor

LGC GROUP LTD

LGC (DRUG DEVELOPMENT SOLUTIONS BUSINESS)

target

LGC (DRUG DEVELOPMENT SOLUTIONS BUSINESS)

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Ampersand-backed Alliance Pharma completed the acquisition of the drug development solutions business from LGC Group.